Skip to Content


In the US, Ulipristal (ulipristal systemic) is a member of the drug class progesterone receptor modulators and is used to treat Birth Control, Emergency Contraception and Uterine Fibroids.

US matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Category

Emergency contraceptive, selective progesterone receptor modulator, SPRM

Chemical Name

11β-[4-(dimetylamino)phenyl]-17-hydroxy-19-norpregna-4,9-diene-3,20-dione (WHO)

Foreign Names

  • Ulipristalum (Latin)
  • Ulipristal (German)
  • Ulipristal (French)
  • Ulipristal (Spanish)

Generic Names

  • Ulipristal (OS: BAN, USAN)
  • Uliprisnil (IS)
  • UNII-6J5J15Q2X8 (IS)
  • Ulipristal Acetate (OS: BANM, USAN)
  • CDB-2914 (IS)
  • HRP 2000 (IS)
  • PGL 4001 (IS)
  • RTI 3021-012 (IS)
  • RU 44675 (IS)
  • Uliprisnil acetate (IS)
  • UNII-YF7V70N02B (IS)
  • VA 2914 (IS)

Brand Names

  • Dvella
    Leon Farma, Georgia
  • EllaOne
    HRA, Tunisia; Laboratoire HRA Pharma, Cyprus
  • Ellaone
    OSNY, Serbia
  • Esmya
    Gedeon Richter, Lithuania; Gedeon Richter, Poland; Gedeon Richter, Slovakia; Gedeon Richter Italia, Italy
  • ella
    Actavis, United States; HRA Pharma, Hong Kong; Hyphens, Malaysia; Hyphens, Singapore
  • Ella
    Laboratoire HRA Pharma, Israel
  • EllaOne
    Arenda, Croatia (Hrvatska); HRA, Hungary; HRA, Romania; HRA, Slovakia; HRA Pharma, Germany; HRA Pharma, Greece; HRA Pharma, Lithuania; HRA Pharma, Portugal; HRA Pharma France, France; HRA Pharma UK and Ireland, United Kingdom; HRA Pharma UK and Ireland, Ireland; Laboratoire HRA Pharma, Austria; Laboratoire HRA Pharma, Bosnia & Herzegowina; Laboratoire HRA Pharma, Czech Republic; Laboratoire HRA Pharma, Poland; Medius, Switzerland; Takeda, Finland
  • Ellaone
    HRA Pharma, Belgium; HRA Pharma, Denmark; HRA Pharma, Spain; HRA Pharma, Norway; HRA Pharma Italia, Italy; Laboratoire HRA, Slovenia
  • ellaOne
    Takeda Pharma, Sweden
  • Esmya
    Gedeon, Portugal; Gedeon Richter, Austria; Gedeon Richter, Belgium; Gedeon Richter, Germany; Gedeon Richter, Denmark; Gedeon Richter, Spain; Gedeon Richter, Finland; Gedeon Richter, France; Gedeon Richter, Georgia; Gedeon Richter, Hungary; Gedeon Richter, Ireland; Gedeon Richter, Latvia; Gedeon Richter, Norway; Gedeon Richter, Russian Federation; Gedeon Richter, Sweden; Gedeon Richter, Slovenia; HRA Pharma, Hong Kong; Preglem, Romania
  • Fibristal
    Actavis Specialty Pharmaceuticals, Canada
  • Inisia
    Shin Poong, South Korea


BANBritish Approved Name
BANMBritish Approved Name (Modified)
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.